After a 13 year drought without approval of any new medications to help combat obesity, the American  Food and Drug Administration (FDA) approved a new medication called lorcaserin (trade name Belviq) this week.

I was asked to write an editorial with my colleague, professor Arne Astrup, for Medscape Today about this new weight loss medication – you can read the full editorial here.

Dr Sue Pedersen © 2012

Follow me on Twitter for daily tips! @drsuepedersen